• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A case description of pulmonary enteric adenocarcinoma with G12D mutation.

作者信息

Fan Fan, Zhang Haijun

机构信息

Department of Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.

出版信息

Quant Imaging Med Surg. 2023 Dec 1;13(12):8787-8792. doi: 10.21037/qims-23-369. Epub 2023 Sep 15.

DOI:10.21037/qims-23-369
PMID:38106325
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10721983/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7032/10721983/e7191559b20d/qims-13-12-8787-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7032/10721983/e4fdecf63a18/qims-13-12-8787-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7032/10721983/20043915744f/qims-13-12-8787-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7032/10721983/b9e7365b5e59/qims-13-12-8787-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7032/10721983/e7191559b20d/qims-13-12-8787-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7032/10721983/e4fdecf63a18/qims-13-12-8787-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7032/10721983/20043915744f/qims-13-12-8787-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7032/10721983/b9e7365b5e59/qims-13-12-8787-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7032/10721983/e7191559b20d/qims-13-12-8787-f4.jpg

相似文献

1
A case description of pulmonary enteric adenocarcinoma with G12D mutation.一例伴有G12D突变的肺肠型腺癌病例描述。
Quant Imaging Med Surg. 2023 Dec 1;13(12):8787-8792. doi: 10.21037/qims-23-369. Epub 2023 Sep 15.
2
Next batter up! Targeting cancers with KRAS-G12D mutations.下一位击球手就位！靶向KRAS-G12D突变的癌症。
Trends Cancer. 2023 Nov;9(11):955-967. doi: 10.1016/j.trecan.2023.07.010. Epub 2023 Aug 15.
3
Loss of heterozygosity for Kras promotes REDD1-dependent, non-canonical glutamine metabolism in pancreatic ductal adenocarcinoma.杂合性缺失促进 Kras 依赖性、非典型谷氨酰胺代谢在胰腺导管腺癌中的发生。
Biochem Biophys Res Commun. 2020 Jun 11;526(4):880-888. doi: 10.1016/j.bbrc.2020.03.137. Epub 2020 Apr 9.
4
KRAS G12D mutation predicts lower TMB and drives immune suppression in lung adenocarcinoma.KRAS G12D突变预示着肺腺癌中较低的肿瘤突变负荷并驱动免疫抑制。
Lung Cancer. 2020 Nov;149:41-45. doi: 10.1016/j.lungcan.2020.09.004. Epub 2020 Sep 10.
5
Preoperative detection of KRAS G12D mutation in ctDNA is a powerful predictor for early recurrence of resectable PDAC patients.ctDNA 中 KRAS G12D 突变的术前检测是可切除 PDAC 患者早期复发的有力预测指标。
Br J Cancer. 2020 Mar;122(6):857-867. doi: 10.1038/s41416-019-0704-2. Epub 2020 Jan 23.
6
G12D Mutation Subtype in Pancreatic Ductal Adenocarcinoma: Does It Influence Prognosis or Stage of Disease at Presentation?胰腺导管腺癌中的 G12D 突变亚型：它是否影响预后或疾病的分期？
Cells. 2022 Oct 10;11(19):3175. doi: 10.3390/cells11193175.
7
Exceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with G12D-mutant lung cancers.侵袭性黏液腺癌的超反应者：硼替佐米治疗G12D突变型肺癌患者的2期试验
Cold Spring Harb Mol Case Stud. 2019 Apr 1;5(2). doi: 10.1101/mcs.a003665. Print 2019 Apr.
8
Critical requirement of SOS1 for tumor development and microenvironment modulation in KRAS-driven lung adenocarcinoma.SOS1 对于 KRAS 驱动的肺腺癌肿瘤发生和微环境调节的关键要求。
Nat Commun. 2023 Sep 20;14(1):5856. doi: 10.1038/s41467-023-41583-1.
9
Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma.阻断白细胞介素-6 转导/STAT3 轴可抑制 Kras 诱导的肺腺癌恶病质。
Oncogene. 2017 May 25;36(21):3059-3066. doi: 10.1038/onc.2016.437. Epub 2016 Nov 28.
10
Wild‑type KRAS inhibits the migration and invasion of pancreatic cancer through the Wnt/β‑catenin pathway.野生型 KRAS 通过 Wnt/β-连环蛋白途径抑制胰腺癌的迁移和侵袭。
Mol Med Rep. 2023 Jan;27(1). doi: 10.3892/mmr.2022.12891. Epub 2022 Nov 11.

引用本文的文献

1
Depicting growth characteristics with computed tomography for KRAS-mutated lung adenocarcinoma.利用计算机断层扫描描绘KRAS突变型肺腺癌的生长特征。
Quant Imaging Med Surg. 2025 May 1;15(5):3942-3949. doi: 10.21037/qims-24-1880. Epub 2025 Apr 27.

本文引用的文献

1
Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases.肺肠型腺癌患者的临床表现和结局：已发表病例的汇总分析。
Lung Cancer. 2023 May;179:107176. doi: 10.1016/j.lungcan.2023.107176. Epub 2023 Mar 22.
2
Adagrasib in Non-Small-Cell Lung Cancer Harboring a Mutation.在携带有突变的非小细胞肺癌中使用阿达格拉西布。
N Engl J Med. 2022 Jul 14;387(2):120-131. doi: 10.1056/NEJMoa2204619. Epub 2022 Jun 3.
3
Anti-PD-(L)1 for KRAS-mutant advanced non-small-cell lung cancers: a meta-analysis of randomized-controlled trials.
抗 PD-(L)1 药物治疗 KRAS 突变型晚期非小细胞肺癌的疗效：一项随机对照试验的荟萃分析。
Cancer Immunol Immunother. 2022 Mar;71(3):719-726. doi: 10.1007/s00262-021-03031-1. Epub 2021 Aug 10.
4
Sotorasib for Lung Cancers with p.G12C Mutation.索托拉西布治疗 p.G12C 突变型肺癌。
N Engl J Med. 2021 Jun 24;384(25):2371-2381. doi: 10.1056/NEJMoa2103695. Epub 2021 Jun 4.
5
Malignancy in giant cell tumor of bone in the extremities.四肢骨巨细胞瘤中的恶性肿瘤
J Bone Oncol. 2020 Nov 5;26:100334. doi: 10.1016/j.jbo.2020.100334. eCollection 2021 Feb.
6
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry.免疫检查点抑制剂治疗晚期肺癌伴致癌驱动基因改变患者：来自 IMMUNOTARGET 登记研究的结果。
Ann Oncol. 2019 Aug 1;30(8):1321-1328. doi: 10.1093/annonc/mdz167.
7
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.帕博利珠单抗对比化疗用于未经治疗、PD-L1 表达、局部晚期或转移性非小细胞肺癌（KEYNOTE-042）：一项随机、开放标签、对照、III 期临床试验。
Lancet. 2019 May 4;393(10183):1819-1830. doi: 10.1016/S0140-6736(18)32409-7. Epub 2019 Apr 4.
8
Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and β-catenin immunostaining for differentiation from metastatic colorectal carcinoma.肺肠型腺癌的临床病理、免疫组化及突变分析：SATB2和β-连环蛋白免疫染色在与转移性结直肠癌鉴别诊断中的应用
Hum Pathol. 2017 Jun;64:179-185. doi: 10.1016/j.humpath.2017.04.006. Epub 2017 Apr 21.
9
Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology.伴有肠化生的肺腺癌：免疫组织化学与分子形态学
Appl Immunohistochem Mol Morphol. 2018 Jul;26(6):383-387. doi: 10.1097/PAI.0000000000000440.
10
Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.《2015年世界卫生组织肺、胸膜、胸腺和心脏肿瘤分类》简介
J Thorac Oncol. 2015 Sep;10(9):1240-1242. doi: 10.1097/JTO.0000000000000663.